| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/19/2009 | EP2089401A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| 08/19/2009 | EP2089395A2 New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities |
| 08/19/2009 | EP2089392A2 3-(dihydro-1h-pyrazolo ý4,3-d¨pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 08/19/2009 | EP2089383A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 08/19/2009 | EP2089364A1 Pyridinone compounds |
| 08/19/2009 | EP2089363A1 Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]n-methylpyridine-2-carboxamide |
| 08/19/2009 | EP2089053A1 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 08/19/2009 | EP2089051A2 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 08/19/2009 | EP2089047A2 Compositions and methods for cardiac tissue protection and regeneration |
| 08/19/2009 | EP2089042A2 Methods for improved engraftment following stem cell transplantation |
| 08/19/2009 | EP2089027A1 Use of iap inhibitors for the treatment of acute myeloid leukemia |
| 08/19/2009 | EP2089024A2 Combination of iap inhibitors and flt3 inhibitors |
| 08/19/2009 | EP1791837B1 Substituted hydantoins for the treatment of cancer |
| 08/19/2009 | EP1641460B1 Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds |
| 08/19/2009 | EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 08/19/2009 | EP1585987B1 Use of adiponectin to diagnose malignancy |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1478339B9 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 08/19/2009 | EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1436286B1 Fumagillol derivatives and preparing method thereof |
| 08/19/2009 | EP1351677A4 Method for treating cancer |
| 08/19/2009 | EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1187918B9 Tek antagonists |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | CN101511870A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 08/19/2009 | CN101511860A SMAC peptidomimetics useful as IAP inhibitors |
| 08/19/2009 | CN101511842A Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
| 08/19/2009 | CN101511841A Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors |
| 08/19/2009 | CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
| 08/19/2009 | CN101511835A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 08/19/2009 | CN101511833A 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 08/19/2009 | CN101511828A Heteroaryl derivatives as protein kinase inhibitors |
| 08/19/2009 | CN101511827A Pyridin-4-yl derivatives as immunomodulating agents |
| 08/19/2009 | CN101511813A Heterocyclic FXR binding compounds |
| 08/19/2009 | CN101511809A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/19/2009 | CN101511801A Triazine derivative compound and composition for treating cancer containing them |
| 08/19/2009 | CN101511798A [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 08/19/2009 | CN101511793A Antitumor agent for undifferentiated gastric cancer |
| 08/19/2009 | CN101511375A Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 08/19/2009 | CN101511372A Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 08/19/2009 | CN101511368A Methods and compositions for promoting activity of anti-cancer therapies. |
| 08/19/2009 | CN101511362A Aqueous formulation comprising an antitumor agent |
| 08/19/2009 | CN101511361A Method of using substituted piperidines that increase p53 activity |
| 08/19/2009 | CN101511359A Benzotriazole kinase modulators |
| 08/19/2009 | CN101511351A Combination methods of treating cancer |
| 08/19/2009 | CN101508989A Radiation sensibility tumor-targeted promotor and uses thereof |
| 08/19/2009 | CN101508979A Recombinant adenovirus carrying human lactoferrin, preparation and uses thereof |
| 08/19/2009 | CN101508739A Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 08/19/2009 | CN101508734A Anti-CD40 monoclonal antibody |
| 08/19/2009 | CN101508731A Trichinella spiralis and tumor-associated antigen protein, preparation and medical use thereof |
| 08/19/2009 | CN101508721A Limited simulation CTL epitope of tumor antigen Ran HLA-A*0201 and uses thereof |
| 08/19/2009 | CN101508719A 11-deoxidized biogastrone acid-3-0-succinic acid half-ester rare earth salt and synthesis thereof |
| 08/19/2009 | CN101508714A Fragrant acid ester derivative of 5-fluorine-2'-deoxidized uridine and synthesis thereof |
| 08/19/2009 | CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use |
| 08/19/2009 | CN101508691A Sulphaminic acid benzothiophene ester derivative used as steroid sulfatase restrainer |
| 08/19/2009 | CN101508689A Synthesis of oroxylin |
| 08/19/2009 | CN101508671A Aza saccharide compounds, synthesis and uses thereof |
| 08/19/2009 | CN101508668A Novel C8 side-chain hydrogenated iso-indole ketone compounds, preparation method and application thereof |
| 08/19/2009 | CN101507821A Medicine for treating malignant cerebroma and breast cancer by combining gene and chemotherapy medicine and preparation method thereof |
| 08/19/2009 | CN101507820A Manufacture of polyglutamate-therapeutic agent conjugates |
| 08/19/2009 | CN101507801A Centipede anti-cancer medicine formula |
| 08/19/2009 | CN101507769A Active component of cortex dictamni and preparation method and use thereof |
| 08/19/2009 | CN101507755A Preparation method of high-purity magnolia bark total-phenol |
| 08/19/2009 | CN101507742A Tridax procumbens total flavone preparation method and use thereof |
| 08/19/2009 | CN101507741A Red beet extract and composite and preparation method and use thereof in preparing medicine for restraining tumor growth |
| 08/19/2009 | CN101507740A Lysimachia capillipes Hemsl. total saponin extract preparation method using macroporous resin and use thereof |
| 08/19/2009 | CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof |
| 08/19/2009 | CN101507737A Active components of gallnut and preparation method and use thereof |
| 08/19/2009 | CN101507730A Combination of epigallocatechin-3-gallate and cerubidin and use thereof |
| 08/19/2009 | CN101507714A Oral preparation containing 7,9-dihydroxy-15-carbonyl-16-kaurene -19,6-lactone |
| 08/19/2009 | CN101507705A Preparation method of block polymer micelle administration system with targeting effect |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529075C Antihuman telomere enzyme reverse transcriptase single-chain antibody |
| 08/19/2009 | CN100528901C Method for separating polysaccharide against growth of cancer cells from dictyophord |
| 08/19/2009 | CN100528897C Modified soluble t cell receptor |
| 08/19/2009 | CN100528889C 1-0-caffeoyl -6-0-(S)-caesalpinia sepiaria acyl group -Beta-D-glucopyranose and uses thereof |
| 08/19/2009 | CN100528886C Metal complex with liriodenine as ligand and its synthesis process and use |
| 08/19/2009 | CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 08/19/2009 | CN100528877C New purine alkaloid and preparation method and application thereof |
| 08/19/2009 | CN100528870C Internal ester monomer compound and its application in preparing anti cancer medicine |
| 08/19/2009 | CN100528869C Silybin flavonolignan and their production method and use |
| 08/19/2009 | CN100528856C Process for producing kuh-seng total flavone and flavone salt |
| 08/19/2009 | CN100528855C Process for producing kuh-seng total flavone and flavone salt by kuh-seng |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528824C Beta-elemene monosubstituted ether derivatives, synthesis method and use thereof |
| 08/19/2009 | CN100528242C Radioactive macroaggregate and its preparation method |
| 08/19/2009 | CN100528239C Method for killing specific tumour cell by recin |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528230C Recombination human MUC1-MBP fusion protein antitumour vaccine and production technology |
| 08/19/2009 | CN100528229C Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 08/19/2009 | CN100528226C Virus-like particles of human papillomavirus |
| 08/19/2009 | CN100528211C Traditional Chinese medicine for treating tumor |